Institut National De La Sante Et De La Recherche Medicale

Targedys

Université´de Rouen

Centre Hospitalier Universitaire De Rouen

Other

Kagoshima University

Inserm (Institut National De La Sante Et De La Recherche Medicale)

Inserm

Fetissov, Serguei

Dechelotte, Pierre

Serguei Fetissov

Pierre Dechelotte

Romain Legrand

Gregory Lambert

Jonathan Breton

Nicolas Lucas

Naouel Tennoune

Emmanuelle De

Philippe Chan-Tchi-Song

Maria Hamze-Sinno

Danièle Gilbert

Grégory Lambert

Akio Inui

Akihiro Asakawa

Kuniko Takagi

The present invention relates to pharmaceutical and food compositions for inducing satiation and prolonging satiety in subjects in need thereof. In particular, the present invention relates to a method of inducing satiation in a subject in need thereof comprising administering to the subject an effective amount of a ClpB protein or an effective amount of a bacterium that expresses the ClpB protein.

Pharmaceutical and food compositions for inducing satiation and prolonging satiety in subjects in need thereof

The present invention relates to method of preventing, treating or attenuating obesity-related manifestations in a human or non-human mammal subject in need thereof, said method comprising orally administering to the subject a composition comprising an effective amountprobiotics; wherein said obesity-related parameters are selected from the group of hyperphagia, increased fat mass on lean mass ratio, increased waist circumference, postprandial hyperglycemia, fasting hyperglycemia and hypercholesterolemia.

Hafnia alvei impact on regulation of appetite and metabolic syndrome aspects

Methods of treating inflammation, in particular obesity, inducing satiation, prolonging satiety, and stimulating weight loss in a subject in need thereof, including the administration of a Brassicaceae protein extract. The Brassicaceae protein extract may be administered in the form of a dietary supplement or a food composition, either of which may include at least one additional ingredient.

protein extract and uses thereof

The present invention relates to pharmaceutical and food compositions for inducing satiation and prolonging satiety in subjects in need thereof. In particular, the present invention relates to a method of inducing satiation in a subject in need thereof comprising administering to the subject an effective amount of

based pharmaceutical and food compositions for inducing satiation and prolonging satiety

The present invention relates to ClpB expressing bacteria and their impact on obesity. The present invention relates to bacterial ClpB protein and ClpB expressing bacteria and their impact on eating disorders. The invention further relates to compositions comprising antibiotic directed against at least one ClpB expressing bacterium as well as probiotics not expressing ClpB protein and their use in the treatment or prevention of eating disorders. The invention also relates to diagnostic tools for determining whether a subject is likely to respond to a method of treating eating disorders and to methods of immunization against eating disorders.

Bacterial influence on regulation of appetite via ClpB protein mimicry of alpha-MSH

The application relates to a method of diagnosing neuropsychiatric diseases, eating disorders and/or metabolic diseases, which comprises: (i) measuring the affinity and/or the avidity of antibodies, derived from a biological sample, directed against a biological molecule involved in homeostatic regulation and/or in motivational behavior and/or in emotion; (ii) comparing the affinity value obtained with a control value.

Method of diagnosing neuropsychiatric diseases, eating disorders or metabolic diseases

Growing community of inventors

Rouen, France

Serguei Fetissov